GeneGene: GNRHR

GnRH receptor (GNRHR)

The gonadotropin-releasing hormone receptor governs the release of LH and FSH. Sustained GnRH-agonist stimulation paradoxically desensitizes the receptor and suppresses sex-hormone production, the basis for halting central precocious puberty.

Forecast a trial in the Arena All targets & genes

Drugs

Trials tracked

Resolved

Indications

Drugs hitting this target

FP-001 (leuprolide mesylate)· Long-acting GnRH-agonist depot

Trials targeting GnRH-R

1 benchmark

ResolvedPhase 3

Casppian Phase 3: FP-001 leuprolide mesylate 42 mg q6mo Central Precocious Puberty (CPP)

FP-001 (leuprolide mesylate) · Central precocious puberty

Dec 24, 2025Clinical Trials

Indications

Central precocious puberty· CPP

About GnRH-R

What is GnRH-R?

Which drugs target GnRH-R?

Therapies acting on GnRH-R tracked here include FP-001 (leuprolide mesylate).

References

Keep exploring

All benchmarks Diseases Drugs Companies

GeneGene: GNRHR

GnRH receptor (GNRHR)

Forecast a trial in the Arena All targets & genes

Drugs

Trials tracked

Resolved

Indications

Drugs hitting this target

FP-001 (leuprolide mesylate)· Long-acting GnRH-agonist depot

Trials targeting GnRH-R

1 benchmark

ResolvedPhase 3

Casppian Phase 3: FP-001 leuprolide mesylate 42 mg q6mo Central Precocious Puberty (CPP)

FP-001 (leuprolide mesylate) · Central precocious puberty

Dec 24, 2025Clinical Trials

Indications

Central precocious puberty· CPP

About GnRH-R

What is GnRH-R?

Which drugs target GnRH-R?

Therapies acting on GnRH-R tracked here include FP-001 (leuprolide mesylate).

References

Keep exploring

All benchmarks Diseases Drugs Companies